Once again, we emphasize the necessity of including latent infections in the investigation and differential diagnosis of lesions in patients on treatment with anti-TNFα drugs, mainly in those who live in or travel to endemic areas. The gene discussed is TNF; the disease is disease arising from reactivation of latent virus.